Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

Bishop, N. et al. (2013) Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial. Lancet, 382(9902), pp. 1424-1432. (doi: 10.1016/S0140-6736(13)61091-0)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1016/S0140-6736(13)61091-0


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Ahmed, Professor Syed Faisal
Authors: Bishop, N., Adami, S., Ahmed, S.F., Anton, J., Arundel, P., Burren, C.P., Devogelaer, J.-P., Hangartner, T., Hosszu, E., Lane, J.M., Lorenc, R., Makitie, O., Munns, C.F., Paredes, A., Pavlov, H., Plotkin, H., Raggio, C.L., Reyes, M.L., Schoenau, E., Semler, O., Sillence, D.O., and Steiner, R.D.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Lancet
Publisher:The Lancet Publishing Group
ISSN:0140-6736

University Staff: Request a correction | Enlighten Editors: Update this record